Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada

Am J Kidney Dis. 2011 Feb;57(2):357-9. doi: 10.1053/j.ajkd.2010.09.025.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Chelating Agents / therapeutic use*
  • Female
  • Humans
  • Hyperphosphatemia / blood
  • Hyperphosphatemia / prevention & control*
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Ontario
  • Polyamines / therapeutic use*
  • Practice Patterns, Physicians'
  • Renal Dialysis*
  • Sevelamer

Substances

  • Chelating Agents
  • Polyamines
  • Sevelamer